Dario Degiorgio

Dr. Dario Degiorgio

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2007 in European Journal of Human Genetics
Verified
Journal Article
Closed access
DDDario Degiorgio
Dario Degiorgio
CCCarla Colombo
Carla Colombo
MSManuela Seia
Manuela Seia
LPLuigi Porcaro
Luigi Porcaro
LCLucy Costantino
Lucy Costantino
DCDomenico Coviello
Domenico Coviello

1 January 2011 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
CCCarla Colombo
Carla Colombo
Pietro VajroPietro Vajro
Pietro Vajro
DDDario Degiorgio
Dario Degiorgio
DCDomenico Coviello
Domenico Coviello
LCLucy Costantino
Lucy Costantino
SCSIGENP Study Group for Genetic Cholestasis
SIGENP Study Group for Genetic Cholestasis

1 September 2015 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
DDDario Degiorgio
Dario Degiorgio
ACAndrea Crosignani
Andrea Crosignani
CCCarla Colombo
Carla Colombo
DBDomenico Bordo
Domenico Bordo
MZMassimo Zuin
Massimo Zuin
PBPier Maria Battezzati
Pier Maria Battezzati

1 January 2012 in Journal of Biomedicine and Biotechnology
Verified
Journal Article
Open access
PDF file
VPValentina Paracchini
Valentina Paracchini
ACAnnalucia Carbone
Annalucia Carbone
Federico Simone ColomboFederico Simone Colombo
Federico Simone Colombo
Stefano CastellaniStefano Castellani
Stefano Castellani
SMSilvia Mazzucchelli
Silvia Mazzucchelli
Massimo ConeseMassimo Conese
Massimo Conese
Cystic fibrosis (CF) is a monogenic disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene, with lung and liver manifestations. Because of pitfalls of gene therapy, novel approaches for reconstitution of the airway epithelium and CFTR expression should be explored. In the present study, human amniotic mesenchymal stem cells (hAMSCs) were isolated from term placentas and characterized for expression of phenotypic and pluripotency markers, and for differentiation potential towards mesoderm (osteogenic and adipogenic) lineages. Moreover, hAMSCs were induced to differentiate into hepatocyte-like cells, as demonstrated by mixed function oxidase activity and expression of albumin, alpha1-antitrypsin, and CK19. We also investigated the CFTR expression in hAMSCs upon isolation and in coculture with CF airway epithelial cells. Freshly isolated hAMSCs displayed low levels of CFTR mRNA, which even decreased with culture passages. Following staining with the vital dye CM-DiI, hAMSCs were mixed with CFBE41o- respiratory epithelial cells and seeded onto permeable filters. Flow cytometry demonstrated that 33–50% of hAMSCs acquired a detectable CFTR expression on the apical membrane, a result confirmed by confocal microscopy. Our data show that amniotic MSCs have the potential to differentiate into epithelial cells of organs relevant in CF pathogenesis and may contribute to partial correction of the CF phenotype.

7 September 2016 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
MCMassimiliano Cecconi
Massimiliano Cecconi
MPMaria I. Parodi
Maria I. Parodi
FFFrancesco Formisano
Francesco Formisano
PSPaolo Spirito
Paolo Spirito
CACamillo Autore
Camillo Autore
DCDomenico Coviello
Domenico Coviello
Hypertrophic cardiomyopathy (HCM) is mainly associated with myosin, heavy chain 7 (MYH7) and myosin binding protein C, cardiac (MYBPC3) mutations. In order to better explain the clinical and genetic heterogeneity in HCM patients, in this study, we implemented a target-next generation sequencing (NGS) assay. An Ion AmpliSeq™ Custom Panel for the enrichment of 19 genes, of which 9 of these did not encode thick/intermediate and thin myofilament (TTm) proteins and, among them, 3 responsible of HCM phenocopy, was created. Ninety-two DNA samples were analyzed by the Ion Personal Genome Machine: 73 DNA samples (training set), previously genotyped in some of the genes by Sanger sequencing, were used to optimize the NGS strategy, whereas 19 DNA samples (discovery set) allowed the evaluation of NGS performance. In the training set, we identified 72 out of 73 expected mutations and 15 additional mutations: the molecular diagnosis was achieved in one patient with a previously wild-type status and the pre-excitation syndrome was explained in another. In the discovery set, we identified 20 mutations, 5 of which were in genes encoding non-TTm proteins, increasing the diagnostic yield by approximately 20%: a single mutation in genes encoding non-TTm proteins was identified in 2 out of 3 borderline HCM patients, whereas co-occuring mutations in genes encoding TTm and galactosidase alpha (GLA) altered proteins were characterized in a male with HCM and multiorgan dysfunction. Our combined targeted NGS-Sanger sequencing-based strategy allowed the molecular diagnosis of HCM with greater efficiency than using the conventional (Sanger) sequencing alone. Mutant alleles encoding non-TTm proteins may aid in the complete understanding of the genetic and phenotypic heterogeneity of HCM: co-occuring mutations of genes encoding TTm and non-TTm proteins could explain the wide variability of the HCM phenotype, whereas mutations in genes encoding only the non-TTm proteins are identifiable in patients with a milder HCM status.

18 September 2013 in European Journal of Human Genetics
Verified
Journal Article
Closed access
DDDario Degiorgio
Dario Degiorgio
PCPaola Corsetto
Paola Corsetto
Angela Maria RizzoAngela Maria Rizzo
Angela Maria Rizzo
CCCarla Colombo
Carla Colombo
MSManuela Seia
Manuela Seia
DCDomenico Coviello
Domenico Coviello